Powder Delivery TRIZ Cases

Lipid nanoparticles deliver modified CFTR mRNA to target cells, resolving immune activation trade-offs while restoring functional protein expression.

pH-sensitive polymer vesicles release encapsulated antibodies into the cytosol, maintaining cell viability.

Vacuum sputtering applies polymer coatings to metal particles, preventing oxidation and agglomeration while preserving magnetic properties.

Inhaled CXCL10 mimic peptides reduce systemic side effects by concentrating therapy in the lung to reverse fibrosis.

High molecular weight proteinoid compounds enable selective tumor accumulation through thermal condensation polymerization.

Intranasal dry powder formulations merge atropine, pralidoxime chloride, and diazepam into a single stable dose to replace complex intramuscular injections.

Cyclodextrin inclusion complexes enable stable inhalable delivery of 1'-cyano carbanucleoside analogs.

An intermediary desiccant absorbs ambient humidity to prevent hygroscopic caking and bridging in stored choline chloride powders.

Hyaluronidase degrades subcutaneous hyaluronic acid to enable systemic enzyme distribution, replacing complex intravenous infusion infrastructure.

Separating contaminated SBTI into pure KTI and BBI fractions eliminates activity variability and ensures consistent oral protein delivery.

Heat treatment at 110°C to 130°C sterilizes freeze-dried earthworm powder while preserving enzyme activity, avoiding the complexity of vacuum drying.

Sugar stabilizers prevent alum gel collapse and aggregation, enabling storage without a cold chain.

Cationic guanylurea peptides bypass efflux pumps to deliver drugs into tumor cells, resolving cellular entry bottlenecks.

Acetalized polyvinyl alcohol microspheres provide intrinsic radiopacity through covalently attached halogens.

Targeting HSPG2 on epithelial-to-mesenchymal transition cells resolves detection gaps in metastatic breast cancer monitoring.

A receptor-selective somatostatin peptide antagonist composition employs a DOTA chelator and antioxidant to prevent radiolytic degradation of the peptide.

Macrophages absorb high purity gold particles to release ions that control the wound chemical milieu, preventing painful and expensive further scarring.

Oral bioavailable silicic acid replaces invasive surgery to treat periodontitis, reducing pocket depths while promoting natural bone regeneration.

Dendrimers bind nucleic acids for precise endonuclease cleavage, creating concatemers that resolve phasing accuracy without increasing sequencing depth.

Decellularized placental tissue fillers minimize injection site inflammation and swelling while providing longer-lasting cosmetic results.

Modified indocyanine green dissolves in organic solvents, enabling scalable solvent evaporation production without complex encapsulation steps.

3-carboxypropyl-aminotetralin compounds block peripheral mu opioid receptors to treat opioid-induced bowel dysfunction while preserving central analgesia.

Selective Jak2 inhibitor compounds block kinase activity through localized molecular interactions, resolving specificity limitations that cause side effects.

Segmented lactose carrier mixing resolves content uniformity trade-offs in dry powder inhalation formulation preparation.

Nanoscale carrier reduces autoimmune reactions by delivering checkpoint inhibitors directly to tumor sites.

Thermal processing of pancreatin at 85°C for 48 hours inactivates viruses without degrading amylase or protease enzymes.

Fourth disulfide bridges stabilize insulin against thermal degradation during high-temperature encapsulation, enabling stable microneedle patches.

Combines MSC-derived extra-cellular vesicles with Alpha-1 antitrypsin protein to modulate immune responses.

Bioreducible poly(disulfide amine) polymers degrade in cytoplasm to release siRNA, resolving cytotoxicity and transfection efficiency trade-offs.

Sugar substrates replace expensive cyclodextrins to solubilize cannabinoids, resolving high costs while improving oral absorption rates.

Centrifugal separation creates an ECM density gradient that improves mechanical integrity and suturing ease while maintaining bioactive component retention.

Maintaining water activity between 0.1 and 0.4 prevents chemical degradation of tiotropium and salmeterol salts with lactose during long-term storage.

Micellar encapsulation stabilizes lipophilic actives in hydrophilic environments, preventing precipitation and boosting plant absorption efficiency.

Optimized 1.5 to 5 μm aerosol droplets deliver beta-hairpin peptidomimetics to resolve lung concentration and device complexity trade-offs.

Nanoparticle carriers deliver inactivated PRRSV antigens to resolve the contradiction between vaccine safety and immunogenicity.

Replacing mammalian excipients with a polymer detergent composite reduces immunogenicity while retaining protein stability.

Composite lipid formulations modulate triglyceride levels while reducing side effects from combination therapies.

CVD silicon particles produce therapeutic hydrogen in situ via redox reactions, eliminating explosion risks from direct gas inhalation.

Water-swellable substances in the formulation maintain high dissolution rates and low related substance formation during storage.

Novel autoantigens enable precise diagnostic accuracy and targeted immunotherapy by identifying specific autoreactive T-cell responses.

A gel-forming X-ray contrast composition transforms from liquid to solid after injection to provide sustained imaging signals.

Inhalable fasudil dry powder formulations deliver RhoA kinase inhibitors directly to the lung, avoiding systemic off-target vascular dilation.

Modified carbon nanostructures transport electrons directly to reduce oxidized species in the mitochondrial electron transport chain.

Migrating reactive end groups to the polymer surface eliminates substrate-damaging pre-treatment steps while enabling stable bio-active molecular attachment.

Transgenic plants express apoA-I mimetic peptides to lower plasma SAA levels and increase paraoxonase activity without complex purification.

Alkylglycoside surfactants prevent protein aggregation in high-concentration formulations, enabling stable storage without cold chain requirements.

A porous pouch wrapper encloses botanical filling material to diffuse solid flavor components through its structure.